Tamoxifen Mylan

Medicinal product

(Invented) name

Tamoxifen Mylan

Active substance (s)

Tamoksifenas

Strength

20 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02BA01, Tamoxifen

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-04-06

Date of renewal

Documents

1506-001-002_Tamoxifen Mylan_2021-04-06.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tamoksifenas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106252	92353	1092353	lizdinė plokštelė	N30		Receptinis	LT/L/21/1506/001	Tiekiama	-	-	No	-	-	Download
106253	92354	1092354	lizdinė plokštelė	N60		Receptinis	LT/L/21/1506/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-04-06	Registruotas